Currently out of the existing stock ratings of David Adlington, 63 are a HOLD (54.31%), 19 are a SELL (16.38%), 34 are a BUY (29.31%).

David Adlington

Work Performance Price Targets & Ratings Chart

Analyst David Adlington, currently employed at JPMORGAN, carries an average stock price target met ratio of 27.23% that have a potential upside of 14.63% achieved within 135 days.

David Adlington’s has documented 207 price targets and ratings displayed on 13 stocks. The coverage is on Healthcare, Communication Services, Financial Services, Energy, Consumer Defensive, Consumer Cyclical sectors.

Most recent stock forecast was given on ALC, Alcon AG at 21-Aug-2025.

Wall Street Analyst David Adlington

Analyst best performing recommendations are on AB (ALLIANCEBERNSTEIN HOLDING L.P.).
The best stock recommendation documented was for AB (ALLIANCEBERNSTEIN HOLDING L.P.) at 3/10/2020. The price target of $14.34 was fulfilled within 2 days with a profit of $3.36 (18.98%) receiving and performance score of 94.92.

Average potential price target upside

FMS Fresenius Medical Care PHG Koninklijke Philips NV ADR SE Sea Ltd SNN Smith & Nephew SNATS FSNUY Fresenius SE KGaA ADR SMMNY Siemens Healthineers AG ADR ALC Alcon AG AMFPF Amplifon S.p.A AB AllianceBernstein Holding L.P. AM Antero Midstream Partners LP CL Colgate-Palmolive Company SM SM Energy Co SON Sonoco Products Company

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 21-Dec-2021

$31.5

18 days ago
(16-Jul-2026)

1/3 (33.33%)

$4.56 (16.93%)

21

Hold Since 24-Feb-2021

$26

$0.34 (1.33%)

$30

6 months 29 days ago
(05-Jan-2026)

9/16 (56.25%)

$2.22 (9.34%)

215

Hold Since 31-Jul-2024

11 months 1 days ago
(02-Sep-2025)

0/2 (0%)

$22.24 (122.81%)

Sell Since 23-Feb-2024

1 years 3 months 12 days ago
(22-Apr-2025)

0/5 (0%)

$23.43 (140.38%)

Hold Since 28-Jan-2025

$85.26

1 years 6 months 6 days ago
(28-Jan-2025)

0/3 (0%)

$49.25 (136.77%)

Show more analysts

Please expand the browser size to see the chart

What Year was the first public recommendation made by David Adlington?

On 2016

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?